Last reviewed · How we verify

NCT03326011

Effect of Gait Training With a Walking Assist Robot on Gait Function and Balance in Patients With Chronic Stroke

Completed NA Last updated 18 April 2018
What this trial tests

NA trial testing Samsung Hip Assist v1 in Gait Disorders, Neurologic in 7 participants. Completed in 28 February 2018.

Timeline
1 November 2017
Primary endpoint
28 February 2018
28 February 2018

Quick facts

Lead sponsorSamsung Medical Center
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposedevice feasibility
Enrollment7
Start date1 November 2017
Primary completion28 February 2018
Estimated completion28 February 2018
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Samsung Medical Center

Who can join

Adults 20 to 84, any sex, with Gait Disorders, Neurologic or Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study was to investigate the effects of gait training with the new wearable hip assist robot developed by Samsung Advance Institute of Technology (Samsung Electronics Co, Ltd, Korea) in patients with chronic stroke.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. European Stroke Organisation Conference: Abstracts
    · 2018

Verify or expand the search:

Other trials of Samsung Hip Assist v1

Trials testing the same drug.

Other recruiting trials for Gait Disorders, Neurologic

Currently open trials in the same condition.

Other Samsung Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03326011.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing